Diet and Cognitive Training in Hematologic Cancer Survivors
A Multi-component Non-pharmacological Intervention to Improve Cognitive Outcomes in Hematologic Cancer Survivors
University of Alabama at Birmingham
80 participants
Nov 22, 2022
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to examine feasibility of a cognitive intervention program in blood cancer survivors. The main questions it aims to answer are: * is it feasible to combine a ketogenic diet supplementation and online cognitive training in an intervention program * will patients using the combined intervention program have improved cognitive functioning compared to those who don't use it * how long will the intervention programs effects last Participants randomized to the intervention arm will consume an exogenous ketogenic supplementation and use an online cognitive training program for 12 weeks, while waitlist arm functions as a control group and will receive the online cognitive training only after a wait period of 12 weeks. Researchers will compare the intervention and waitlist control groups to see if the intervention improves cognitive functioning.
Eligibility
Inclusion Criteria6
- Adult with hematologic malignancy diagnosed at age ≥21 years
- Outpatient at least 3 months from completion of blood or marrow transplant (BMT) or at least 6 months from diagnosis for patients not treated with BMT
- Evidence of mild-to-moderate cognitive impairment using either the Modified Telephone Interview for Mild Cognitive Impairment (TICS-M) or PROMIS 8a short form raw score = 19 -37
- Have daily access to an internet-connected home computer
- Can fluently read and write in English
- Can understand and sign the study-specific Informed Consent Form
Exclusion Criteria8
- History of pre-existing neurological disorder or documented major psychiatric disorder
- Significant auditory, visual, or motor impairments
- History of color blindness
- Participated in neuropsychological intervention within the past 6 months
- Evidence of active chronic graft vs. host disease (GvHD) for allogeneic BMT
- History of pre-existing metabolic disease
- Allergies to soy or milk
- Body Mass Index (BMI) ≤20
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will follow a modified ketogenic diet consuming a daily exogenous ketogenic meal replacement formula while limiting their carbohydrate intake for 12 weeks.
Participants will complete a daily session of 5 online cognitive training tasks for 12 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05708716